Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 39129 

Company FR docket Published 

Restek Corporation ................................................................................................................... 83 FR 27634 June 13, 2018. 

Bellwyck Clinical Services ........................................................................................................ 83 FR 27633 June 13, 2018. 

Cambrex Charles City .............................................................................................................. 83 FR 27633 June 13, 2018. 

The Drug Enforcement 

Administration (DEA) has considered 

the factors in 21 U.S.C. 823, 952(a) and 

958(a) and determined that the 

registration of the listed registrants to 

import the applicable basic classes of 

schedule I or II controlled substances is 

consistent with the public interest and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. The 

DEA investigated each company’s 

maintenance of effective controls 

against diversion by inspecting and 

testing each company’s physical 

security systems, verifying each 

company’s compliance with state and 

local laws, and reviewing each 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 

952(a) and 958(a), and in accordance 

with 21 CFR 1301.34, the DEA has 

granted a registration as an importer for 

schedule I or II controlled substances to 

the above listed companies. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16941 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Bulk Manufacturer of Controlled 

Substances Application: Euticals Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 9, 2018. 

ADDRESS: Written comments should be 

sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.33(a), this is notice that on June 

25, 2018, Euticals, Inc., 2460 W Bennett 

Street, Springfield, Missouri 65807– 

1229 applied to be registered as a bulk 

manufacturer of the following basic 

classes of controlled substances: 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Amphetamine ............... 1100 II 

Lisdexamfetamine ........ 1205 II 

Methylphenidate ........... 1724 II 

Phenylacetone .............. 8501 II 

Methadone .................... 9250 II 

Methadone intermediate 9254 II 

Oripavine ...................... 9330 II 

Tapentadol .................... 9780 II 

The company plans to manufacture 

the above-listed controlled substances 

in bulk for distribution to its customers. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16942 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Chattem Chemicals, Inc. 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 7, 2018. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 7, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 

3417, (January 25, 2007) 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on August 

16, 2017, Chattem Chemicals, Inc., 3801 

St. Elmo Avenue, Chattanooga, 

Tennessee 37409 applied to be 

registered as an importer of the 

following basic classes of controlled 

substances: 

Controlled 

substance 

Drug 

code Schedule 

Methamphetamine ........ 1105 II 

4-Anilino-N-phenethyl-4- 

piperidine (ANPP).

8333 II 

Phenylacetone .............. 8501 II 


sradovich on DSK3GMQ082PROD with NOTICES
39130 Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices 

Controlled 

substance 

Drug 

code Schedule 

Opium, raw ................... 9600 II 

Poppy Straw Concentrate.9670 II 

Tapentadol .................... 9780 II 

The company plans to import the 

listed controlled substances to 

manufacture bulk controlled substances 

for sale to its customers. The company 

plans to import an intermediate form of 

tapentadol (9780), to bulk manufacture 

tapentadol for distribution to its 

customers. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16940 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–392] 

Importer of Controlled Substances 

Application: Myoderm 

ACTION: Notice of application. 

DATES: Registered bulk manufacturers of 

the affected basic classes, and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 7, 2018. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 7, 2018. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DRW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for hearing must be 

sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/LJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DRW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

Comments and requests for hearings on 

applications to import narcotic raw 

material are not appropriate. 72 FR 

3417, (January 25, 2007) 

SUPPLEMENTARY INFORMATION: The 

Attorney General has delegated his 

authority under the Controlled 

Substances Act to the Administrator of 

the Drug Enforcement Administration 

(DEA), 28 CFR 0.100(b). Authority to 

exercise all necessary functions with 

respect to the promulgation and 

implementation of 21 CFR part 1301, 

incident to the registration of 

manufacturers, distributors, dispensers, 

importers, and exporters of controlled 

substances (other than final orders in 

connection with suspension, denial, or 

revocation of registration) has been 

redelegated to the Assistant 

Administrator of the DEA Diversion 

Control Division (‘‘Assistant 

Administrator’’) pursuant to section 7 of 

28 CFR part 0, appendix to subpart R. 

In accordance with 21 CFR 

1301.34(a), this is notice that on October 

5, 2017, Myoderm, 48 East Main St., 

Norristown, Pennsylvania 19401 

applied to be registered as an importer 

of the following basic classes of 

controlled substances: 

Controlled 

substance 

Drug 

code Schedule 

Amphetamine ............... 1100 II 

Lisdexamfetamine ........ 1205 II 

Methylphenidate ........... 1724 II 

Nabilone ....................... 7379 II 

Oxycodone ................... 9143 II 

Hydromorphone ............ 9150 II 

Hydrocodone ................ 9193 II 

Morphine ....................... 9300 II 

Oxymorphone ............... 9652 II 

Fentanyl ........................ 9801 II 

The company plans to import 

controlled substances commercially 

packaged in dosage form only for 

clinical trials purposes, research, and 

analytical purposes only. 

Dated: July 31, 2018. 

John J. Martin, 

Assistant Administrator. 

[FR Doc. 2018–16938 Filed 8–7–18; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employment and Training 

Administration 

Agency Information Collection 

Activities; Comment Request; State 

Apprenticeship Expansion (SAE) 

Grants Research Study 

ACTION: Notice of information collection; 

request for comment. 

SUMMARY: The Department of Labor 

(DOL), Employment and Training 

Administration (ETA) is soliciting 

comments concerning a new request for 

the authority to conduct the information 

collection request (ICR) titled, ‘‘State 

Apprenticeship Expansion (SAE) Grants 

Research Study.’’ This comment request 

is part of continuing Departmental 

efforts to reduce paperwork and 

respondent burden in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). 

DATES: Consideration will be given to all 

written comments received by October 

9, 2018. 

ADDRESSES: A copy of this ICR with 

applicable supporting documentation; 

including a description of the likely 

respondents, proposed frequency of 

response, and estimated total burden 

may be obtained free by contacting 

Gloribel Nieves-Cartagena by telephone 

at (202) 693–2771, TTY 1–877–889– 

5627 (these are not toll free numbers), 

or by email at NievesCartagena.Gloribel@dol.gov. 

Submit written comments about, or 

requests for a copy of, this ICR by mail 

or courier to the U.S. Department of 

Labor, Employment and Training 

Administration, Office of Policy 

Development and Research, Room N– 

5641, 200 Constitution Avenue NW, 

Washington, DC 20210; by email: 

Nieves-Cartagena.Gloribel@dol.gov; or 

by Fax at (202) 693–2766. 

FOR FURTHER INFORMATION CONTACT: 

Gloribel Nieves-Cartagena by telephone 

at (202) 693–2771, TYY 1–877–889– 

5627 (these are not toll-free numbers) or 

by email at Nieves-Cartagena.Gloribel@

dol.gov. 

Authority: 44 U.S.C. 3506(c)(2)(A). 

SUPPLEMENTARY INFORMATION: The DOL, 

as part of its continuing effort to reduce 

paperwork and respondent burden, 

conducts a pre-clearance consultation 

program to provide the general public 

and Federal agencies with an 

opportunity to comment on proposed 

and/or continuing collections of 

information before submitting them to 

the OMB for final approval. This 

program helps to ensure that requested 

data can be provided in the desired 

format, reporting burden (time and 

financial resources) is minimized, 

collection instruments are clearly 

understood, and the impact of collection 

requirements on respondents is properly 

assessed. 

The information collection activities 

described in this notice will provide 

data for a qualitative study of 

Apprenticeship SAE grants and related 

apprenticeship expansion activities. 

Through grant and contract vehicles, 

DOL is seeking to expand opportunities 

related to Registered Apprenticeships, 

expand programs to new industries and 

occupations, increase the number of 

apprentices, and to promote the 

diversity and inclusion of apprentices. 


sradovich on DSK3GMQ082PROD with NOTICES